06/09/2014 - 12:45pm

BioDelivery Sciences International on Monday announced that the Food and Drug Administration approved its new drug application for Bunavail (buprenorphine and naloxone) buccal film (CIII).

06/09/2014 - 12:15pm

A report published Friday in the Morbidity and Mortality Weekly Report characterized the 2013-2014 influenza season as the first season since 2009 that H1N1 generated fewer levels of outpatient illness and mortality as compared with seasons when influenza A (H3N2) is predominant.

06/09/2014 - 11:32am

The Office of the National Coordinator for Health Information Technology last week issued a policy paper, "A 10-Year Vision to Achieve an Interoperable Health IT Infrastructure," which outlines the government's pledge to support interoperable electronic health records to most Americans.

06/09/2014 - 10:22am

Teva on Monday announced that the Food and Drug Administration approved an expanded label for Azilect (rasagiline tablets) from monotherapy and adjunct to levodopa to now include dopamine agonists.

06/06/2014 - 12:18pm

The Centers for Disease Control and Prevention recently updated a health advisory, recommending an inactivated poliovirus booster for adults traveling to countries with an active wild polio virus in circulation.

06/06/2014 - 12:00pm

Upsher-Smith Laboratories on Wednesday announced that it has received final approval from the Food and Drug Administration for its new drug application for Vogelxo (testosterone) gel for topical use CIII.

06/06/2014 - 11:05am

The Senate confirmed former Walmart executive Sylvia Burwell as Secretary of the Department of Health and Human Services on Thursday by a vote of 78-17, according to several reports.

06/04/2014 - 2:48pm

The Deparment of Health and Human Services on Wednesday announced the availability of up to $300 million under the Affordable Care Act to help the nation’s community health centers expand service hours, hire more medical providers, and add oral health, behavioral health, pharmacy and vision services.

06/03/2014 - 2:42pm

Indian drug maker Wockhardt has been charged by the Food and Drug Administration with utilizing the same unapproved method to test drug quality in its Morton Grove, Ill., facility as two facilities in India, both of which were subsequently banned from importing into the United States,the Wall Street Journal reported Tuesday.